NICE (UK) recommends danicopan as add on to ravulizumab or eculizumab to treat residual haemolytic anaemia – AstraZeneca
NICE (UK): Danicopan (Voydeya) from Alexion/AstraZeneca, is recommended, as an add-on to ravulizumab or eculizumab as an option for treating paroxysmal nocturnal haemoglobinuria (PNH) in adults who have… read more.
